| Financial Year |
March 31 2023 |
| Monetary Funds |
54,980,156.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,927,261.19 |
| Accounts Receivable |
70,257,363.39 |
| Advances to Suppliers |
24,709,219.76 |
| Other Receivables |
5,555,578.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,779,588.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,529,592.88 |
| Total Current Assets |
385,724,095.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
19,345,661.49 |
| Fixed Assetes |
89,028,754.87 |
| Under-construction Projects |
10,974,660.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,695,626.57 |
| R&D expenses |
-- |
| Goodwill |
24,014,575.17 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,972,837.64 |
| Other Non-Current Assets |
33,715,338.86 |
| Sub-Total of Non-Current Assets |
220,388,037.74 |
| Total Assets |
606,112,133.41 |
| Short-Term Loans |
106,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,000,000.00 |
| Accounts Payable |
82,776,750.79 |
| Accounts Received In Advance |
144,861.99 |
| Employee Compensation Payable |
6,275,047.99 |
| Taxes Payable |
14,164,155.29 |
| Interest Payable |
-- |
| Dividend Payable |
2,443,291.91 |
| Other payables |
123,219,651.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,378,763.27 |
| Other Current Liabilities |
7,275,692.22 |
| Sub-Total of Current Liabilities |
388,341,892.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,844,900.26 |
| Other Non-Current Liabilities |
942,070.55 |
| Sub-Total of Non-Current Liabilities |
14,714,218.10 |
| Total Liabilities |
403,056,110.63 |
| Paid-In Capital(Or Share Stock) |
1,073,128,052.00 |
| Capital Surplus |
250,782,222.21 |
| Surplus Reserve |
19,749,258.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,208,500,779.97 |
| Minority Stockholder's Interest |
71,651,019.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
131,405,002.90 |
| Owner's Equity（Stockholder's Equity） |
203,056,022.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
606,112,133.41 |
